ESAR - European Surveillance of Antibiotic Resistance
All in-patients; infection and discipline known; 1999 and 2000
Therapy

Type of Infection: Wound infection
  Total Type of therapy
missing Prophylaxis Treatment
N % N % N % N %
Substance 44 14.29 16 5.19 7 2.27 21 6.82
aminopenicillin + -lact.inh.
aminoglycosides 42 13.64 27 8.77 4 1.30 11 3.57
3rd gen. cephalosporins 39 12.66 13 4.22 4 1.30 22 7.14
polypeptides 37 12.01 15 4.87 2 0.65 20 6.49
quinolones 34 11.04 14 4.55 1 0.32 19 6.17
2nd gen. cephalosporins 17 5.52 7 2.27 2 0.65 8 2.60
lincosamides 16 5.19 12 3.90 1 0.32 3 0.97
aminopenicillin 11 3.57 7 2.27 - - 4 1.30
methylpenicillin 11 3.57 2 0.65 - - 9 2.92
glycopeptide 9 2.92 6 1.95 - - 3 0.97
carbapenems 8 2.60 5 1.62 - - 3 0.97
penicillins 7 2.27 1 0.32 - - 6 1.95
macrolides 6 1.95 2 0.65 - - 4 1.30
sulfonamides 5 1.62 4 1.30 - - 1 0.32
antifungals 5 1.62 2 0.65 2 0.65 1 0.32
acylaminopenicillin + -lact.inh. 4 1.30 3 0.97 - - 1 0.32
1st gen. cephalosporins 3 0.97 1 0.32 - - 2 0.65
cephalosporin 3 0.97 2 0.65 - - 1 0.32
tetracyclines 2 0.65 1 0.32 - - 1 0.32
4th gen. cephalosporins 2 0.65 - - - - 2 0.65
urinary anti-infectives 2 0.65 2 0.65 - - - -
topical antiinfectives 1 0.32 - - - - 1 0.32
Total 308 100.00 142 46.10 23 7.47 143 46.43

ESBiC Study Center